tradingkey.logo

CeriBell Inc

CBLL
查看详细走势图
21.420USD
+0.130+0.61%
收盘 12/24, 13:00美东报价延迟15分钟
793.58M总市值
亏损市盈率 TTM

CeriBell Inc

21.420
+0.130+0.61%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+0.61%

5天

-2.59%

1月

+40.37%

6月

+15.85%

今年开始到现在

-17.23%

1年

-19.84%

查看详细走势图

TradingKey CeriBell Inc股票评分

单位: USD 更新时间: 2025-12-23

操作建议

CeriBell Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名39/208位。机构持股占比非常高,近一月多位分析师给出公司评级为强力买入。最高目标价26.00。中期看,股价处于上升通道。近一个月,市场表现很强,技术面和基本面综合得分较高,很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

CeriBell Inc评分

相关信息

行业排名
39 / 208
全市场排名
113 / 4568
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 8 位分析师
强力买入
评级
26.000
目标均价
+28.59%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

CeriBell Inc亮点

亮点风险
CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
业绩高增长
公司营业收入稳步增长,连续3年增长152.47%
业绩增长期
公司处于发展阶段,最新年度总收入65.44M美元
估值合理
公司最新PE估值-15.13,处于3年历史合理位
机构减仓
最新机构持股30.92M股,环比减少0.09%
PRFDX持仓
明星投资者PRFDX持仓,最新持仓市值2.34K

CeriBell Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

CeriBell Inc简介

CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
公司代码CBLL
公司CeriBell Inc
CEOChao (Xingjuan)
网址https://ceribell.com/

常见问题

CeriBell Inc(CBLL)的当前股价是多少?

CeriBell Inc(CBLL)的当前股价是 21.420。

CeriBell Inc的股票代码是什么?

CeriBell Inc的股票代码是CBLL。

CeriBell Inc股票的52周最高点是多少?

CeriBell Inc股票的52周最高点是27.215。

CeriBell Inc股票的52周最低点是多少?

CeriBell Inc股票的52周最低点是10.010。

CeriBell Inc的市值是多少?

CeriBell Inc的市值是793.58M。

CeriBell Inc的净利润是多少?

CeriBell Inc的净利润为-40.45M。

现在CeriBell Inc(CBLL)的股票是买入、持有还是卖出?

根据分析师评级,CeriBell Inc(CBLL)的总体评级为--,目标价格为26.000。

CeriBell Inc(CBLL)股票的每股收益(EPS TTM)是多少

CeriBell Inc(CBLL)股票的每股收益(EPS TTM)是-1.407。
KeyAI